Phase 1/2 AAV5-hRKp.RPGR (Botaretigene Sparoparvovec) Gene Therapy: Safety and Efficacy in RPGR-Associated X-Linked Retinitis Pigmentosa
MICHAELIDES, MICHEL, BESIRLI, CAGRI G., YANG, YESA, DE GUIMARAES, THALES A.C., WONG, SUI CHIEN, HUCKFELDT, RACHEL M., COMANDER, JASON I., SAHEL, JOSÉ-ALAIN, SHAH, SYED MAHMOOD, TEE, JAMES J.L., KUMARAN, NERUBAN, GEORGIADIS, ANASTASIOS, MINNICK, PANSY, ZELDIN, ROBERT, NAYLOR, STUART, XU, JIALIN, CLARK, MICHAEL, ANGLADE, EDDY, WONG, PEGGY, FLECK, PENNY R., FUNG, ALBERT, PELUSO, COLLEEN, KALITZEOS, ANGELOS, GEORGIOU, MICHALIS, RIPAMONTI, CATERINA, SMITH, ALEXANDER J., ALI, ROBIN R., FORBES, ALEXANDRIA, BAINBRIDGE, JAMES
Published in American journal of ophthalmology (01.11.2024)
Published in American journal of ophthalmology (01.11.2024)
Get full text
Journal Article